CONTEXT: Spontaneous intramural duodenal hematoma is uncommon and is usually associated with coagulopathy, anticoagulant therapy and endoscopic procedures. The aim here was to describe a case of intramural duodenal hematoma caused by chronic exacerbation of pancreatitis. CASE REPORT: A 46-year-old male with chronic alcoholic pancreatitis was admitted to hospital due to abdominal pain, melena and low hemoglobin. An intramural duodenal hematoma with active bleeding was detected and selective angioembolization was warranted. The patient evolved with a perforated duodenum and underwent laparotomy with exclusion of the pylorus and Roux-en-Y gastrojejunostomy. He was discharged nine days later. CONCLUSION: Intramural duodenal hematoma is a rare complication of pancreatitis. Selective embolization is the preferred treatment for hemorrhagic complications of pancreatitis. However, the risk of visceral ischemia and perforation should be considered.
INTRODUCTION
The first description of an intramural duodenal hematoma was made by McLauchlan in 1838.
This condition is usually associated with blunt abdominal trauma. Spontaneous intramural duodenal hematoma is uncommon and has been linked to coagulopathy, anticoagulant therapy and endoscopic procedures. [1] [2] [3] Other causes include several pancreatic diseases, collagenosis, peptic ulcers and pancreaticoduodenal aneurysm. [4] [5] [6] [7] To date, the exact mechanism leading to intramural hematoma in cases of pancreatitis has not yet been fully elucidated and the prognosis has not yet been completely defined, mainly due to its scarcity. 1, 3, [5] [6] [7] [8] [9] This study sought to describe a case of an intramural duodenal hematoma caused by chronic exacerbation of pancreatitis.
CASE REPORT
The patient (JCAP) was a 43-year-old white male who had been a chronic abuser of alcohol for 25 years (two liters of distilled liquor/day), with an antecedent of acute pancreatitis five years before the present case report. He had been complaining of strong typical pain for three days, along with melena.
At admission to hospital, the following test results were noted: leukogram = 15,000 u/l, hemoglobin = 16 g/dl and amylase = 99 IU/l. A computed tomography (CT) scan showed signs of chronic pancreatitis and a bulky submucosal duodenal hematoma from the bulb to the third portion of the duodenum with intramural active bleeding in the region of the gastroduodenal artery ( Figure 1A) . Upper digestive tract endoscopy revealed a large submucosal hematoma in the duodenum, without any active bleeding into the lumen (Figure 2 ).
On the following day, the hemoglobin level decreased to 12 g/dl and selective angioembolization was indicated. During angiography, active bleeding was detected ( Figure 3A) . After embolization, no more signs of active bleeding were observed ( Figure 3B ). 
DISCUSSION
Duodenal hematomas have been described as complications of both acute and chronic pancreatitis. Acute pancreatitis is a common disease, with an incidence of 20 to 40 cases/100,000 personyears of life and a mortality rate close to 5%, and the vast majority of the cases are of biliary etiology. 10 On the other hand, chronic pancreatitis is a progressive inflammatory disorder characterized by irreversible destruction of the pancreatic parenchyma and may Emergency laparotomy was warranted and revealed the following:
an ischemic duodenum with a bulky wall hematoma and a 6-cm were requested from their authors. Articles presenting potentially relevant studies were read and analyzed to assess the inclusion criteria. We excluded articles that consisted of in vitro or animal studies, articles in which the participants' characteristics did not match those mentioned above, poster session abstracts, review articles and other types of publications. Articles that described traumatic or iatrogenic duodenal hematomas were also excluded. Other papers were used for contextualization and discussion.
After extensive online research, we identified 14 studies, which were all single case reports. The majority of the previously reported cases showed that conservative therapy was possible, but this method is associated with lengthier hospital stay and a need for transfusion of blood components.
Interventional therapies may include surgical repair using endoscopic and endovascular techniques. The benefits of endoscopy include its minimally invasive nature, compared with other treatment options, and the absence of radiation exposure. However, it has limitations, given that it cannot be used for areas of bleeding that are inaccessible to the intestinal lumen. 8 Arterial embolization seems to be effective for management of bleeding. Embolization is considered successful when both radiologically and clinically there is evidence of bleeding control characterized by hemoglobin stabilization and absence of signs and symptoms of shock. 18, 19 Laparotomy for bleeding therapy should only be considered for hemodynamically unstable patients. Advances in endovascular radiology have led to this method becoming the preferred treatment option. 18 The present case demonstrates the need for a high degree of suspicion that the diagnosis could comprise bleeding caused by pancreatitis, as well as the need to remain open to the possibility of a severe and rare complication after embolization (visceral perforation). This complication requires rapid intervention, because the risk of mortality that it presents is up to 10 times greater than that commonly observed in cases of acute pancreatitis. 20, 21 The currently available evidence consists solely of single case reports, which thus precludes final conclusions regarding the optimal therapy. Hence, further research is necessary.
CONCLUSION
Intramural duodenal hematoma is a rare complication of pancreatitis. Selective embolization is the preferred treatment, but the risk of visceral ischemia and perforation should be considered. 
